Example: Heart Attack

Search clinical trials for: Phenylacetic acid

Total 16 results

NCT04155567

Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male Participants

Conditions: Healthy Volunteers
NCT04128462

Not yet recruiting

MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain Function

Conditions: Hepatic Encephalopathy
NCT03846843

Completed

OCR002-SP103 - Oral Immediate Release Study

Conditions: Cirrhosis
NCT03712280

Recruiting

MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)

Conditions: Hepatic Cirrhosis; Hepatic Encephalopathy (HE)
NCT03159390

Active, not recruiting

Metabolism of Ornithine Phenylacetate

Conditions: Healthy
NCT01966419

Completed

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

Conditions: Acute Episode of Overt Hepatic Encephalopathy; Hepatic Encephalopathy
NCT01634230

Completed

Emergency Use of OCR-002 in Acute Liver Failure (ALF)

Conditions: Acute Liver Failure
NCT01548690

Completed

Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury

Conditions: Acute Liver Failure; Acute Liver Injury
NCT01434108

Completed

Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding

Conditions: Gastrointestinal Bleeding; Cirrhosis
NCT00986895

Completed

A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group

Conditions: Hepatic Encephalopathy; Urea Cycle Disorders
NCT00977600

Completed

A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P)

Conditions: Healthy
NCT00597909

Terminated

Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

Conditions: Hepatic Encephalopathy
NCT00003241

Completed

Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors

Conditions: Brain and Central Nervous System Tumors
NCT00001565

Completed

Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy

Conditions: Brain Neoplasms; Neuroblastoma
NCT00006450

Completed

Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors

Conditions: Brain Tumor
NCT00004767

Completed

Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders

Conditions: Amino Acid Metabolism, Inborn Errors